Hindustan Times News | 3rd February 2022 | 6 PM

HT Daily News Wrap

BJP lawmaker Nishikant Dubey on Thursday moved a breach of privilege motion against Rahul Gandhi, Schools, colleges and universities reopened in West Bengal on Thursday & and other top news in this bulletin.
BJP lawmaker Nishikant Dubey on Thursday moved a breach of privilege motion against Rahul Gandhi. The motion in response to the ‘inciting’ speech Gandhi made in Parliament yesterday. The Congress leader had slammed the Centre for allegedly destroying the idea of India by ruling it like a kingdom. He added the Constitution described India as a Union of states but BJP’s vision is to rule with a stick. The Supreme Court on Thursday declined to postpone the GATE exam. It said that postponement will create chaos and uncertainty in the lives of students who have registered for the exam. The bench headed by Justice DY Chandrachud dismissed the petitions. The GATE exam is scheduled to be held on February 5, 6, 12 and 13. Two petitions were filed in the issue – one of them by the students. Schools, colleges and universities reopened in West Bengal on Thursday. The decision has been taken due to a fall in Covid-19 cases in the state. The state government also plans to open neighbourhood schools for pre-primary and primary students from Monday. Schools in Bengal were shut for the first time in March 2020 due to the Covid-19 pandemic. The winter olympics will begin in Beijing on Friday at a turbulent time. There is a virtual clampdown with thousands of participants inside a tight bio-bubble. This has been done due to China’s strict zero Covid policy. China is also under fire over its human rights record. Activists want athletes to raise their voice over the government’s treatment of Muslim Uyghurs in Xinjiang province. A study has revealed that the hepatitis E virus defies alcohol-based hand disinfectants. This is the most common cause of acute virus-mediated hepatitis worldwide. The study was published in the Journal of Hepatology. The researchers partnered industry leaders for the study. They were able to show that most formulations did not completely inactivate the virus.